[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[2]
|
Park, J.Y., Seong, S.J., Kim, T.J., et al. (2017) Significance of Body Weight Change during Fertility Sparing Progestin Therapy in Young Women with Early Endometrial Cancer. Gynecologic Oncology, 146, 39-43.
https://doi.org/10.1016/j.ygyno.2017.05.002
|
[3]
|
Dallal, C.M., Lacey Jr., J.V., Pfeiffer, R.M., et al. (2016) Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: The B-FIT Cohort. Hormones and Cancer, 7, 49-64.
https://doi.org/10.1007/s12672-015-0237-y
|
[4]
|
Shivappa, N., Hébert, J.R., Zucchetto, A., et al. (2016) Dietary Inflammatory Index and Endometrial Cancer Risk in an Italian Case-Control Study. British Journal of Nutrition, 115, 138-146. https://doi.org/10.1017/S0007114515004171
|
[5]
|
Friedenreich, C.M., Biel, R.K., Lau, D.C., et al. (2011) Case-Control Study of the Metabolic Syndrome and Metabolic Risk Factors for Endometrial Cancer. Cancer Epidemiology, Biomarkers & Prevention, 20, 2384-2395.
https://doi.org/10.1158/1055-9965.EPI-11-0715
|
[6]
|
Cohen, A., Lim, C.S. and Davies, A.H. (2017) Venous Thromboembolism in Gynecological Malignancy. International Journal of Gynecological Cancer, 27, 1970-1978. https://doi.org/10.1097/IGC.0000000000001111
|
[7]
|
Satoh, T., Matsumoto, K., Uno, K., et al. (2008) Silent Venous Thromboembolism before Treatment Inendometrial Cancer and the Risk Factors. British Journal of Cancer, 99, 1034-1039. https://doi.org/10.1038/sj.bjc.6604658
|
[8]
|
Fiorica, J.V., Brunetto, V.L., Hanjani, P., et al. (2004) Gynecologic Oncology Group Study. Phase II Trial of Alternating Courses of Megestrol Acetate and Tamoxifen in Advanced Endometrial Carcinoma: A Gynecologic Ncology Group Study. Gynecologic Oncology, 92, 10-14. https://doi.org/10.1016/j.ygyno.2003.11.008
|
[9]
|
Noda, K., Wada, H., Yamada, N., et al. (2000) Changes of Hemostatic Molecular Markers after Gynecological Surgery. Clinical and Applied Thrombosis/Hemostasis, 6, 197-201. https://doi.org/10.1177/107602960000600403
|
[10]
|
Petereit, D.G., Sarkaria, J.N. and Chappell, R.J. (1998) Perioperative Morbidity and Mortality of High-Dose-Rate Gynecologic Brachytherapy. International Journal of Radiation Oncology, Biology, Physics, 42, 1025-1031.
https://doi.org/10.1016/S0360-3016(98)00349-6
|
[11]
|
Petera, J., Odrazka, K., Frgala, T., et al. (2005) External Beam Radiotherapy and High-Dose Brachytherapy Combined with Cisplatin and Paclitaxel in Patients with Advanced Cervical Carcinoma. Gynecologic Oncology, 99, 334-338.
https://doi.org/10.1016/j.ygyno.2005.06.015
|
[12]
|
Jacobson, G.M., Kamath, R.S., Smith, B.J., et al. (2005) Thromboembolic Events in Patients Treated with Definitive Chemotherapy and Radiation Therapy for Invasive Cervical Cancer. Gynecologic Oncology, 96, 470-474.
https://doi.org/10.1016/j.ygyno.2004.10.023
|
[13]
|
王杉, 俞耀军. 腹腔镜胃癌根治术与开腹手术对胃癌患者凝血功能及免疫功能的影响[J]. 中国现代医生, 2015, 53(10): 5-8.
|
[14]
|
金碧霞, 孔为民. “国际妇产科联盟(FIGO)2018癌症报告: 子宫内膜癌诊治指南”解读[J]. 中国临床医生杂志, 2019, 47(10): 1155-1158.
|
[15]
|
Shtherland, D.E., Wettz, I.C. and Lieman, H.A. (2003) Thromboembolic Omplication of Cancer: Epideology, Pathogenesis, Diagnosis and Treatment. American Journal of Hematology, 72, 43-52. https://doi.org/10.1002/ajh.10263
|
[16]
|
赵文华. 恶性肿瘤流行趋势分析及预防的研究[J]. 天津科技, 2006, 33(3): 38.
|
[17]
|
王仲, 袁娟. D-二聚体与肿瘤血栓形成[J]. 现代肿瘤医学, 2014, 22(3): 38.
|
[18]
|
Falanga, A., Marchetti, M. and Vignoli, A. (2013) Coagulation and Cancer: Biological and Clinical Aspects. Journal of Thrombosis and Haemostasis, 11, 223-233. https://doi.org/10.1111/jth.12075
|
[19]
|
Wada, H., Sase, T. and Yamaguchi, M. (2005) Hypercoagulant States in Malignant Lymphoma. Experimental Oncology, 27, 179.
|
[20]
|
Van Es, N., Sturk, A., Middeldorp, S., et al. (2014) Effects of Cancer on Platelets. Seminars in Oncology, 41, 311-318.
https://doi.org/10.1053/j.seminoncol.2014.04.015
|
[21]
|
Mego, M., Karaba, M., Minarik, G., et al. (2015) Relationship between Circulating Tumor Cells, Blood Coagulation, and Urokinase-Plasminogen-Activator System in Early Breast Cancer Patients. The Breast, 21, 155-160.
https://doi.org/10.1111/tbj.12388
|
[22]
|
Ay, C., Dunkler, D., Pirker, R., et al. (2012) High D-Dimer Levels Are Associated with Poor Prognosis in Cancer Patients. Haematologica, 97, 1158-1164. https://doi.org/10.3324/haematol.2011.054718
|
[23]
|
Tinholt, M., Sandset, P.M., Mowinckel, M.C., et al. (2016) Determinants of Acquired Activated Protein C Resistance and D-Dimer in Breast Cancer. Thrombosis Research, 145, 78-83. https://doi.org/10.1016/j.thromres.2016.08.003
|
[24]
|
Go, S.I., Lee, M.J., Lee, W.S., et al. (2015) D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by Chemotherapy. Medicine, 94, 951. https://doi.org/10.1097/MD.0000000000000951
|
[25]
|
Zhu, L., Liu, B., Zhao, Y., et al. (2014) High Levels of D-Dimer Correlated with Disease Status and Poor Prognosis of Inoperable Metastatic Colorectal Cancer Patients Treated with Bevacizumab. Journal of Cancer Research and Therapeutics, 10, 246-251. https://doi.org/10.4103/0973-1482.151451
|
[26]
|
Chen, Y., Yu, H., Wu, C., et al. (2016) Prognostic Value of Plasma D-Dimer Levels in Patients with Small-Cell Lung Cancer. Biomedicine & Pharmacotherapy, 81, 210-217. https://doi.org/10.1016/j.biopha.2016.02.030
|
[27]
|
Chen, W.H., Tang, L.Q., Wang, F.W., et al. (2014) Elevated Levels of Plasma D-Dimer Predict a Worse Outcome in Patients with Nasopharyngeal Carcinoma. BMC Cancer, 14, 583. https://doi.org/10.1186/1471-2407-14-583
|